Related Experiment Video
Updated: Nov 6, 2025

08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.0K
Therapeutic approaches for SARS-CoV-2 infection
Ankur Gupta1, Anish Pradhan1, Vimal K Maurya2
1Government Pharmacy College, Sajong, Rumtek, Gangtok 737135, India.
Methods (San Diego, Calif.)
|May 7, 2021
Summary
Effective COVID-19 treatments are needed, as specific drugs remain unavailable. This review explores diverse therapeutic strategies, including drug discovery and complementary medicine, to combat SARS-CoV-2.
Area of Science:
- Virology
- Drug Discovery
- Immunology
Background:
- No specific antiviral drugs are currently available for COVID-19 treatment, despite ongoing research.
- Understanding the SARS-CoV-2 life cycle and host responses is crucial for developing effective therapies.
- Complementary and alternative medicine (CAM) shows potential in enhancing immune responses and patient resilience.
Purpose of the Study:
- To summarize and analyze various therapeutic antiviral strategies for COVID-19 drug discovery.
- To explore novel approaches including drug repurposing, natural products, and phage technology.
- To understand mechanistic pathways for targeting SARS-CoV-2 and host immunity.
Main Methods:
- Review of computer-aided drug design, including high throughput virtual screening (HTVS).
- Analysis of repurposed drugs, novel synthetic compounds, and natural product discovery.
- Examination of immunomodulators, vaccines, plasma therapy, and phage technology.
Main Results:
- Multiple therapeutic avenues are being investigated, ranging from small molecule inhibitors to advanced biotechnologies.
- Understanding host-pathogen interactions and host factors (nutrition, metabolism, lifestyle) informs therapeutic strategies.
- Integrated approaches combining conventional and CAM may offer improved outcomes.
Conclusions:
- A multifaceted therapeutic strategy is essential for effective COVID-19 containment.
- Continued research into drug discovery, repurposing, and immune modulation is vital.
- Exploring diverse approaches, including CAM, can enhance treatment efficacy and patient recovery.
Related Concept Videos
Pneumonia IV: Management
541
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
541
Microorganisms in Medicine and Therapeutics
603
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
603
Acute Respiratory Failure-V
264
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
264
Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Tumor Immunotherapy
804
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
804
Myocarditis III: Medical Management
45
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
45

